As of November 2024, ADMA Biologics has a market cap of $4.23B. This makes ADMA Biologics the world's 3151th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.19B | 16.59% |
2023 | $1.02B | 16.49% |
2022 | $876.76M | 175.18% |
2021 | $318.61M | -27.69% |
2020 | $440.64M | -51.25% |
2019 | $903.87M | 67.36% |
2018 | $540.06M | -25.55% |
2017 | $725.36M | -37.30% |
2016 | $1.16B | -36.56% |
2015 | $1.82B | -27.75% |
2014 | $2.52B | 43.21% |
2013 | $1.76B | - |